卡瑟普辛C抑制降低中性粒细胞血清蛋白酶活性,并改善激活中性粒细胞介导疾病
Yuka Nishibata1, Suishin Arai1, Mai Taniguchi1
1Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan.
Nature communications
|August 22, 2024
概括
素C (CatC) 抑制剂,如MOD06051,可以减少中性粒细胞的激活和中性粒细胞外细胞陷 (NET) 的形成. 这表明,CatC抑制对于由中性粒细胞驱动的炎症性疾病是一种有前途的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲素C (CatC) 调节中性粒细胞血清蛋白酶 (NSP),对中性粒细胞激活至关重要.
- 活性中性粒细胞和中性粒细胞外细胞陷 (NETs) 与炎症性疾病有关.
研究的目的:
- 评估CatC抑制剂在涉及NET的疾病中的治疗潜力.
- 研究CatC抑制对中性粒细胞激活和NET形成的影响.
主要方法:
- 在体外评估CatC抑制剂MOD06051对NSP活性,包括中性粒细胞弹性酶 (NE).
- 对接受MOD06051.1治疗的老鼠中性粒细胞中NE活性和NET形成的评估.
- 将MOD06051给肌氧化酶 (MPO) - 抗核素细胞质抗体相关血管炎 (AAV) 的老鼠模型,以评估治疗效果.
主要成果:
- MOD06051在体外以剂量为依赖的方式抑制了NSP活性.
- 接受MOD06051治疗的老鼠的中性粒细胞显示NE活性降低和NET形成.
- 在MPO-AAV.的小鼠模型中,MOD06051改善了血管炎和降低了NETs.
结论:
- 素C的抑制有效地减少了中性粒细胞的激活和NET的形成.
- MOD06051证明了对MPO-AAV.等炎症状况的治疗潜力.
- 向CatC提供了一个有希望的策略来管理中性粒细胞介导疾病.
更多相关视频
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
568
19:16The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
20.6K
相关概念视频
Caspases
12.4K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.4K
The Proteasome
8.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K
